Results 151 to 160 of about 5,789 (161)
Some of the next articles are maybe not open access.

Facioscapulohumeral muscular dystrophy (FSHD) molecular diagnosis: from traditional technology to the NGS era

Neurogenetics, 2019
Raffaella Cascella   +2 more
exaly  

Myoblasts from affected and non-affected FSHD muscles exhibit morphological differentiation defects

Journal of Cellular and Molecular Medicine, 2010
Gilles Carnac   +2 more
exaly  

DUX4 expression in FSHD muscle cells: how could such a rare protein cause a myopathy?

Journal of Cellular and Molecular Medicine, 2013
Alexandra Belayew   +2 more
exaly  

DUX4 Expression in FSHD Muscles: Focus on Its mRNA Regulation

Journal of Personalized Medicine, 2020
Laura Le Gall   +2 more
exaly  

Methylation of the FSHD Syndrome-Linked Subtelomeric Repeat in Normal and FSHD Cell Cultures and Tissues

Molecular Genetics and Metabolism, 2001
Baodong Sun, Melanie Ehrlich
exaly  

Correlation analysis of clinical parameters with epigenetic modifications in the DUX4 promoter in FSHD

Epigenetics, 2012
Silvère M van der Maarel   +2 more
exaly  

The FSHD-linked locus D4F104S1 (p13E-11) ON 4q35 has a homologue on 10qter

Muscle and Nerve, 1995
Bert Bakker   +2 more
exaly  

FSHD-like patients without 4q35 deletion

Journal of the Neurological Sciences, 2004
Ichizo Nishino   +2 more
exaly  

snRNA-seq analysis in multinucleated myogenic FSHD cells identifies heterogeneous FSHD transcriptome signatures associated with embryonic-like program activation and oxidative stress-induced apoptosis.

Human Molecular Genetics
Silvère M van der Maarel   +2 more
exaly  

The Facioscapulohumeral Muscular Dystrophy Rasch-Built Overall Disability Scale (FSHD-RODS): Longitudinal Assessment of a Disease-Specific Patient Reported Outcome

European Journal of Neurology
Nens van Alfen   +2 more
exaly  
facioscapulohumeral muscular dystrophy
dux4
medicine
genetics
muscular dystrophy
biomarker
epigenetics
previous   14  15  16  17  

Home - About - Disclaimer - Privacy